Automation tools from two software makers target cardiac safety in clinical trials. ERT's Centralized Cardiac Safety 2.0 helps researchers store and access the ECGs generated during trials from a central location.
Version 2.0 technology resides in the company's Expert operating platform. It works with the ELI-PC, a hand-held ECG collection device under license from Mortara Instrument. The ELI-PC communicates with the central database, allowing test-result communication and pre-trial download of patient demographics.
Separately, cardiac diagnostic technology provider NewCardio has announced that a U.S.-based CRO is licensing the QTinno software solution for automated cardiac toxicity analyses via QT interval studies in early-phase drug development. The technology provider also has signed a services work order, which includes development of SOPs and validation kits, to aid the CRO in offering ECG core lab services to its sponsor customers.
- here's the ERT announcement
- see the NewCardio item